These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 17105880

  • 1. Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure.
    Parissis JT, Adamopoulos S, Farmakis D, Filippatos G, Paraskevaidis I, Panou F, Iliodromitis E, Kremastinos DT.
    Heart; 2006 Dec; 92(12):1768-72. PubMed ID: 17105880
    [Abstract] [Full Text] [Related]

  • 2. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E, Erturk M, Birant A, Kurtar Mansıroglu A, Akturk IF, Karakurt H, Yalcin AA, Uzun F, Somuncu MU, Yildirim A.
    Cardiol J; 2015 Dec; 22(1):87-93. PubMed ID: 24846511
    [Abstract] [Full Text] [Related]

  • 3. The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure.
    Cetin M, Uçar O, Cicekçioğlu H, Güven Cetin Z, Sahin M, Vasfi Ulusoy F, Aydoğdu S.
    Acta Cardiol; 2012 Jun; 67(3):317-23. PubMed ID: 22870740
    [Abstract] [Full Text] [Related]

  • 4. Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure.
    Parissis JT, Panou F, Farmakis D, Adamopoulos S, Filippatos G, Paraskevaidis I, Venetsanou K, Lekakis J, Kremastinos DT.
    Am J Cardiol; 2005 Aug 01; 96(3):423-6. PubMed ID: 16054474
    [Abstract] [Full Text] [Related]

  • 5. Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure.
    Tasal A, Demir M, Kanadasi M, Bacaksiz A, Vatankulu MA, Sahin DY, Eker RA, Bozkurt A, Acarturk E.
    Med Sci Monit; 2014 Feb 19; 20():276-82. PubMed ID: 24549281
    [Abstract] [Full Text] [Related]

  • 6. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

  • 7. Effects of levosimendan on heart failure in normotensive patients: does loading dose matter?
    Palmerini E, Söderberg S, Mondillo S, Favilli R, Lunghetti S.
    Acute Card Care; 2015 Mar 01; 17(1):14-9. PubMed ID: 25806830
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up.
    Sargento L, Brito D, Matias JS, Madeira H.
    Rev Port Cardiol; 2007 Mar 01; 26(7-8):717-26. PubMed ID: 17939581
    [Abstract] [Full Text] [Related]

  • 9. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.
    Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W.
    Circulation; 2000 Oct 31; 102(18):2222-7. PubMed ID: 11056096
    [Abstract] [Full Text] [Related]

  • 10. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
    Bergh CH, Andersson B, Dahlström U, Forfang K, Kivikko M, Sarapohja T, Ullman B, Wikström G.
    Eur J Heart Fail; 2010 Apr 31; 12(4):404-10. PubMed ID: 20335355
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
    Hou ZQ, Sun ZX, Su CY, Tan H, Zhong X, Hu B, Zhou Y, Shang DY.
    Cardiovasc Ther; 2013 Apr 31; 31(2):108-14. PubMed ID: 23490237
    [Abstract] [Full Text] [Related]

  • 15. Levosimendan in decompensated heart failure patients: efficacy in a Brazilian cohort. Results of the BELIEF study.
    Bocchi EA, Vilas-Boas F, Moreira Mda C, Barretto AC, Lage S, Albuquerque D, Baima J, Rassi S, Ribeiro JP, Investigators of BELIEF Study, Heart Failure Working Group of Brazilian Society of Cardiology.
    Arq Bras Cardiol; 2008 Mar 31; 90(3):182-90. PubMed ID: 18392398
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT, Paraskevaidis I, Bistola V, Farmakis D, Panou F, Kourea K, Nikolaou M, Filippatos G, Kremastinos D.
    Am J Cardiol; 2006 Dec 01; 98(11):1489-92. PubMed ID: 17126656
    [Abstract] [Full Text] [Related]

  • 18. Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival.
    Malfatto G, Della Rosa F, Villani A, Rella V, Branzi G, Facchini M, Parati G.
    J Cardiovasc Pharmacol; 2012 Nov 01; 60(5):450-5. PubMed ID: 22932705
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure.
    Husebye T, Eritsland J, Bjørnerheim R, Andersen GØ.
    Eur Heart J Acute Cardiovasc Care; 2018 Jun 01; 7(4):321-329. PubMed ID: 28045338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.